These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Induced abortion: Guidelines for clinical practice - Text of the Guidelines (short text)]. Vayssière C; Gaudineau A; Attali L; Bettahar K; Eyraud S; Faucher P; Fournet P; Hassoun D; Hatchuel M; Jamin C; Letombe B; Linet T; Msika Razon M; Ohanessian A; Segain H; Vigoureux S; Winer N; Wylomanski S; Agostini A J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1596-1603. PubMed ID: 27818117 [TBL] [Abstract][Full Text] [Related]
7. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW; Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236 [TBL] [Abstract][Full Text] [Related]
8. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial. Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372 [TBL] [Abstract][Full Text] [Related]
9. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar]. Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423 [TBL] [Abstract][Full Text] [Related]
11. [Management of first trimester miscarriages]. Beucher G; Beillat T; Dreyfus M J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1):5-21. PubMed ID: 12592177 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage. Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165 [TBL] [Abstract][Full Text] [Related]
14. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F; Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235 [TBL] [Abstract][Full Text] [Related]
16. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial. Kong GW; Lok IH; Yiu AK; Hui AS; Lai BP; Chung TK Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):170-7. PubMed ID: 23488984 [TBL] [Abstract][Full Text] [Related]
17. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy]. Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562 [TBL] [Abstract][Full Text] [Related]
18. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Ngai SW; Chan YM; Tang OS; Ho PC Hum Reprod; 2001 Jul; 16(7):1493-6. PubMed ID: 11425836 [TBL] [Abstract][Full Text] [Related]
19. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage. Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872 [TBL] [Abstract][Full Text] [Related]
20. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial. Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]